Personalis, Inc. PSNL Proceeds From Sale Of Common Stock Under Merck Investment Agreement
Proceeds From Sale Of Common Stock Under Merck Investment Agreement at other companies
Other financials
Where this comes from
Reported directly by Personalis, Inc. in its filing.
Tagged under the XBRL concept psnl:ProceedsFromSaleOfCommonStockUnderMerckInvestmentAgreement.
The official record: Personalis, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Personalis, Inc.'s proceeds from sale of common stock under merck investment agreement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Personalis, Inc.'s proceeds from sale of common stock under merck investment agreement?
- Personalis, Inc. (PSNL) reported proceeds from sale of common stock under merck investment agreement of $12.5M in Q4 2024.
- What does proceeds from sale of common stock under merck investment agreement mean?
- This represents the cash inflows resulting from the sale of equity to a specific corporate partner under a strategic investment agreement. It serves as a measure of the company's ability to attract capital from industry leaders to fund research and development or commercial expansion. Tracking this helps investors assess the company's reliance on strategic partners for funding.